HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.

Abstract
Uroporphyrinogen decarboxylase activity was measured in hemoglobin-free lysates from two patients with hepatoerythropoietic porphyria (HEP) and from 12 unrelated patients with familial porphyria cutanea tarda (PCT). In HEP patients, enzyme activities were 5% of normal, and familial studies clearly confirmed that patients with HEP are cases of homozygous PCT. Immunoreactive uroporphyrinogen decarboxylase was measured by developing a direct and noncompetitive enzyme immunoassay (EIA). For the 12 familial PCT patients, we found an immunoreactive protein decreased (51%) to the same extent as the catalytic activity (48%) [cross-reactive immunological material ( CRIM ) negative]. The children from the HEP family were also CRIM negative, contrasting with another HEP family previously described as CRIM positive; our data support the hypothesis of a heterogeneity in familial uroporphyrinogen decarboxylase deficiency.
AuthorsH de Verneuil, C Beaumont, J C Deybach, Y Nordmann, Z Sfar, R Kastally
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 36 Issue 3 Pg. 613-22 (May 1984) ISSN: 0002-9297 [Print] United States
PMID6375356 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Porphyrins
  • Carboxy-Lyases
  • Uroporphyrinogen Decarboxylase
Topics
  • Carboxy-Lyases (deficiency)
  • Child
  • Diseases in Twins
  • Erythrocytes (enzymology)
  • Female
  • Homozygote
  • Humans
  • Immunoenzyme Techniques
  • Liver Diseases (enzymology, genetics)
  • Male
  • Pedigree
  • Porphyrias (enzymology, genetics)
  • Porphyrins (analysis)
  • Skin Diseases (enzymology, genetics)
  • Uroporphyrinogen Decarboxylase (analysis, deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: